Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6307)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 24, 2022 (publication date) through Apr 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nteli P, Bajwa DE, Politakis D, Michalopoulos C, Kefala-Narin A, Efstathopoulos EP, Gazouli M. Nanomedicine approaches for treatment of hematologic and oncologic malignancies. World J Clin Oncol 2022; 13(7): 553-566 [PMID: 36157164 DOI: 10.5306/wjco.v13.i7.553] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v13/i7/553.htm |
| Number | Citing Articles |
| 1 |
Abdurraouf Mokhtar Mahmoud, Clara Deambrogi. Advancements in Nanotechnology for Targeted and Controlled Drug Delivery in Hematologic Malignancies: Shaping the Future of Targeted Therapeutics. Applied Biosciences 2025; 4(1): 16 doi: 10.3390/applbiosci4010016
|
| 2 |
Stavros P. Papadakos, Nikolaos Machairas, Ioanna E. Stergiou, Konstantinos Arvanitakis, Georgios Germanidis, Adam Enver Frampton, Stamatios Theocharis. Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation. Cells 2023; 12(16): 2036 doi: 10.3390/cells12162036
|
| 3 |
Zaid Saad Madhi, Mohammed Ali Shallan, Abdulhusein Mizhir Almaamuri, Ammar Abbas Alhussainy, Sadiq Salam S. AL- Salih, Abdulla K. Raheem, Hameed Jassem Alwan, Abduladheem Turki Jalil. Lipids and lipid derivatives for delivery of the CRISPR/Cas9 system. Journal of Drug Delivery Science and Technology 2022; 78: 103948 doi: 10.1016/j.jddst.2022.103948
|